RecruitingNot ApplicableNCT05929820

Impact of Protect Your Colon™ on CRC Screening

Pilot Randomized Controlled Trial Assessing the Impact of Protect Your Colon™ on Colorectal Cancer Screening Behaviors


Sponsor

Cedars-Sinai Medical Center

Enrollment

184 participants

Start Date

Sep 28, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of the research is to assess the impact of Protect Your Colon™, a colorectal cancer (CRC) screening decision aid, on patients' CRC screening behaviors. The Investigators hypothesize that Protect Your Colon™, through optimizing shared decision making, will lead to selection of a test that accurately matches patients' values and increase CRC screening uptake. To test this hypothesis, the investigators will conduct a pilot randomized controlled trial (RCT) to assess if provision of Protect Your Colon™ improves communication on CRC screening, intent to complete screening, and ultimately uptake of screening vs. usual care.


Eligibility

Min Age: 45 YearsMax Age: 75 Years

Inclusion Criteria4

  • Individuals 45 to 75 years old
  • No prior CRC screening or not up-to-date with CRC screening
  • Not at high risk for CRC (e.g., inflammatory bowel disease, colon polyposis syndromes, family history of CRC)
  • No prior colon polyps

Exclusion Criteria3

  • Does not speak English
  • Does not have internet access
  • Any records flagged "break the glass" or "research opt out."

Interventions

BEHAVIORALProtect Your Colon™

Protect Your Colon™ is an online decision aid focused on CRC screening. The site will first educate patients on the importance of CRC screening and offer information on the advantages and disadvantages of the available test options. Protect Your Colon™ will then present an interactive conjoint analysis-a quantitative survey technique that elucidates how individuals make complex decisions-to precisely determine individuals' latent preferences regarding CRC screening options. Afterwards, the app will generate a personalized report that rank orders the importance of each test attribute (e.g., accuracy, invasiveness, test frequency) in patients' decision making and identifies the screening modality that best matches their preferences. The report will also be shareable with physicians, enabling patients and providers to engage in shared decision making surrounding CRC screening in the clinic.


Locations(1)

Cedars-Sinai Medical Center

Los Angeles, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05929820


Related Trials